Patent Assignment Details
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
|
| Reel/Frame: | 019216/0281 | |
| Pages: | 6 |
| | Recorded: | 04/26/2007 | | |
| Attorney Dkt #: | 1708.0280002/MAC/SAS |
| Conveyance: | CORRECTIVE ASSIGNMENT TO CORRECT THE DATE ASSOCIATED WITH REGISTRATION OF THE TRADE NAME AS ENTERED IN THE EXECUTION DATE BOX PREVIOUSLY RECORDED ON REEL 015462 FRAME 0103. ASSIGNOR(S) HEREBY CONFIRMS THE PARALLEL TRADE NAME WAS REGISTERED 04.28.2000 PARALLEL TRADE NAME (ENGLISH): BIOTIE THERAPIES CORP.. |
|
|
Total properties:
1
|
|
|
|
Patent #:
|
|
Issue Dt:
|
05/03/2005
|
Application #:
|
10005647
|
Filing Dt:
|
12/07/2001
|
|
Publication #:
|
|
Pub Dt:
|
09/12/2002
| | | | |
|
Title:
|
GLUCURONYL C5-EPIMERASE, DNA ENCODING THE SAME AND USES THEREOF
|
|
|
Assignee
|
|
|
|
|
| TYKISTOKATU 6, |
| TURKU, FINLAND 20520 |
|
|
Correspondence name and address
|
| |
STERNE, KESSLER, GOLDSTEIN & FOX P.L.L.C
|
| |
1100 NEW YORK AVENUE, N.W.
|
| |
WASHINGTON, DC 20005
|
Search Results as of:
05/29/2024 12:39 PM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
|
